This page provides real time results for CDRH’s customer satisfaction survey for the current rating period. About the Survey: On June 16, 2014, CDRH launched the Customer Satisfaction survey. The survey was revised between December 14, 2015 and February 1, 2016. CDRH measures customer satisfaction in six months intervals. CDRH Customer Satisfaction Rating: Results below…
Consumer Information on: AspireAssist
This is a brief overview of information related to FDA’s approval to market this product. See the links below to the Summary of Safety and Effectiveness Data (SSED) and product labeling for more complete information on this product, its indications for use, and the basis for FDA’s approval. Product Name: AspireAssistPMA Applicant: Aspire Bariatrics, Inc.Address:…
Presentation and Transcript added to Artificial Pancreas: A Dialogue between the FDA and the Diabetes Community
<!– –> <!– Page Last Updated: 06/10/2016 –> Page Last Updated: 06/10/2016 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Dissemination of Patient-Specific Information from Devices by Device Manufacturers
%PDF-1.4 % 1 0 obj /OutputIntents[] /Metadata 154 0 R endobj 2 0 obj endobj 3 0 obj /XObject/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] /MediaBox[ 0 0 612 792] /Contents 4 0 R/StructParents 0 endobj 4 0 obj stream xY]o}GHhQ@6즸YlE%;Bm)wfhŦl:..X43gPeSNI~et4~ktgʚ~}_O’+D’E’X,Jqo’ϗӓݯ7|KAvzy:2m7bnP-pWJ.dGW1*oRhif48L8JEzxMC rCVLk͎7ګMsKv
Presentations posted for June 2-3, 2016 Circulatory System Devices Panel of the Medical Devices Advisory Committee
<!– –> <!– Page Last Updated: 06/08/2016 –> Page Last Updated: 06/08/2016 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
24 Hour Summary posted for June 2-3, 2016 Circulatory System Devices Panel of the Medical Devices Advisory Committee
%PDF-1.7 % 288 0 obj stream x]_sԱuOu:i3smӸ$ؤN2}m?Fy
Webinar: Announcing Final Guidance on Postmarket Surveillance Under Section 522 of the Food, Drug, and Cosmetic Act and FDA Webinar on the Final Guidance on June 28, 2016
On June 28, 2016, the FDA will hold a webinar for industry to review the Postmarket Surveillance Under Section 522 of the Food, Drug, and Cosmetic Act guidance document. Section 522 of the Federal, Food, Drug and Cosmetic Act (the Act) provides the FDA with the authority to require device manufacturers to conduct postmarket surveillance…
Summary Information for: Bard® LifeStent Vascular Stent System
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
May 2016 PMA Approvals
%PDF-1.7% 6742 0 objstream hyq2
Summary Information for: VENTANA PD-L1 (SP142) Assay
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.